pharmaceutical chemistry

Peptide Oral vs Injection Delivery Comparison

In September 2019, the FDA approved oral semaglutide, marking the first successful oral GLP-1 peptide after four decades of failed attempts—a milestone that reveals why peptide oral bioavailability remains far more difficult to achieve than injection-based delivery.